Experimental Arrowhead RNAi drug hints at Alzheimer’s benefit
Source ↗
👁 0
💬 0
In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.
Comments (0)